Krsnaa Diagnostics Share Price

NSE
KRSNAA •
BUY

1W Return

1M Return

6M Return

1Y Return

3Y Return

The current prices are delayed, login or Open Demat Account for live prices.
Start SIP in Krsnaa Diagnostics
Stock Performance
52 Week Low - High
Today’s Low - High

Open

Prev. Close

Total Traded Value

View details of Market Depth
Fundamental

Market Cap (in crs)

Face Value

Turnover (in lacs)

Key Metrics
Qtr Change %
30.29% Fall from 52W High
-25.1
TTM PE Ratio
Below industry Median
31.1
Price to Book Ratio
Below industry Median
2.8
Dividend yield 1yr %
Above industry Median
0.3
TTM PEG Ratio
PEG TTM is less than 1
1

Krsnaa Diagnostics Key Financials

View more

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

*All values are in ₹ Cr.

Krsnaa Diagnostics Quarterly Revenue

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
174.51 Cr
186.34 Cr
170.23 Cr
166.28 Cr
158.32 Cr

Krsnaa Diagnostics Yearly Revenue

Mar 2024Mar 2023Mar 2022
636.43 Cr
506.5 Cr
470.36 Cr

Krsnaa Diagnostics Quarterly Net Profit/Loss

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
19.42 Cr
19.6 Cr
17.92 Cr
18.73 Cr
12.97 Cr

Krsnaa Diagnostics Yearly Net Profit/Loss

Mar 2024Mar 2023Mar 2022
56.84 Cr
62.11 Cr
68.39 Cr
Krsnaa Diagnostics Result Highlights
  • Krsnaa Diagnostics Ltd reported a 3.8% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3FY25). On a year-on-year (YoY) basis, it witnessed a growth of 13.1%.

  • Its expenses for the quarter were down by 4.4% QoQ and up 8.2% YoY.

  • The net profit decreased 0.9% QoQ and increased 49.7% YoY.

  • The earnings per share (EPS) of Krsnaa Diagnostics Ltd stood at 5.9 during Q3FY25.

    Read more

Data Source: BSE, Company announcements

The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results.

Krsnaa Diagnostics shareholding Pattern

Promoter
27.2%
Foreign Institutions
4%
Mutual Funds
9.8%
Domestic Institutions
14.5%
Public
54.3%
Promoter
27.2%
Foreign Institutions
3.6%
Mutual Funds
11.6%
Domestic Institutions
15.9%
Public
53.3%
Promoter
27.2%
Foreign Institutions
3.3%
Mutual Funds
11.9%
Domestic Institutions
15.3%
Public
54.2%
Promoter
27%
Foreign Institutions
3.3%
Mutual Funds
11%
Domestic Institutions
15.4%
Public
54.3%
Promoter
27%
Foreign Institutions
3.4%
Mutual Funds
11.9%
Domestic Institutions
16.6%
Public
52.9%
Promoter
27.8%
Foreign Institutions
3.7%
Mutual Funds
14%
Domestic Institutions
18.7%
Public
49.8%

Krsnaa Diagnostics Technical Analysis

Moving Averages Analysis
Moving Averages Analysis
Current Price
Bullish Moving Averages
1
Bearish Moving Averages
15
5Day EMA
738.90
10Day EMA
762.00
12Day EMA
770.10
20Day EMA
794.10
26Day EMA
807.00
50Day EMA
837.10
100Day EMA
840.90
200Day EMA
798.60
5Day SMA
725.30
10Day SMA
765.50
20Day SMA
809.80
30Day SMA
822.50
50Day SMA
851.30
100Day SMA
879.80
150Day SMA
833.00
200Day SMA
779.50
Delivery & Volume

Delivery & Volume

PeriodCombined Delivery VolumeNSE+BSE Traded Volume
Day Rs
23025 Rs
45405 Rs
Week Rs
49996 Rs
92644 Rs
Month Rs
37072 Rs
69969 Rs
Resistance & Support
736.27
Pivot
Resistance
First Resistance
752.53
Second Resistance
777.27
Third Resistance
793.53
Support
First Support
711.53
Second support
695.27
Third Support
670.53
Relative Strength Index
33.04
Money Flow Index
19.79
MACD
-36.96
MACD Signal
-27.03
Average True Range
39.80
Average Directional Index
27.39
Rate of Change (21)
-11.65
Rate of Change (125)
0.17

Krsnaa Diagnostics Company background

Founded in: 2010
Managing director: Pallavi Bhatevara,
Krsnaa Diagnostics Limited was originally incorporated as Krsna Diagnostics Private Limited at Pune, Maharashtra dated December 22, 2010. The Company name was changed to Krsnaa Diagnostics Private Limited, pursuant to a fresh Certificate of Incorporation issued by the RoC on January 29, 2015. Thereafter, the status got converted into a Public Company and the name was changed to Krsnaa Diagnostics Limited pursuant to a fresh Certificate of Incorporation issued by the RoC on 06 May, 2021. The Company is primarily engaged in providing diagnostic services centres all over India. The company is providing Radiology and Pathology services for Xray, CT Scan, MRI, Mammography, TeleReporting services, all type of blood and urine investigation and other related diagnostic services. The Company owns an extensive network of integrated diagnostics centres across India primarily in nonmetro and lowertier cities and towns, with operating 1823 diagnostics centres offering radiology and pathology services in 13 states across the country. The Company started operating 12 centres in Himachal Pradesh in public private partnership during the period 2012. It installed 50 centres in 4 states in 2017 and expanded operations across 13 states in 2018. Further, it expanded the operations to over 1500 centres across India in 2020. The Company in August 2021, came up with an Initial Public Offer of 12,741,036 Equity Shares by raising funds from public aggregating to Rs.1213.33 Crore, comprising a Fresh Issue of 4,215,516 Equity Shares aggregating to Rs 400 Crore and an Offer for Sale of 8,525,520 Equity Shares aggregating to Rs. 813.33 Crore.The Company operationalized 26 radiology centers, 50 pathology labs, and 556 collection centers in 202223. It expanded geographical presence from 660+ centers in FY 2018 to over 2,800 centers in FY 2023. The Teleradiology hub in Pune achieved prestigious accreditationfrom the National Accreditation Board for Hospitals Healthcare Providers (NABH) during the year 2023. The Company expanded its geographical presence to more than 3600 centres in FY 2024.
Read More

Krsnaa Diagnostics FAQs

Krsnaa Diagnostics share price is ₹727.8 in NSE and ₹728 in BSE as on 20/2/2025 12:00:00 AM. Please be aware that stock prices are subject to continuous fluctuations due to various factors.

Krsnaa Diagnostics share price in the past 1-year return was 6.9. The Krsnaa Diagnostics share hit a 1-year low of Rs. 528.05 and a 1-year high of Rs. 1044.

The market cap of Krsnaa Diagnostics is Rs. 2350.05 Cr. as of 20/2/2025 12:00:00 AM.

The PE ratios of Krsnaa Diagnostics is 29.32 as of 20/2/2025 12:00:00 AM.

The PB ratios of Krsnaa Diagnostics is 2.76 as of 20/2/2025 12:00:00 AM

The Mutual Fund Shareholding in Krsnaa Diagnostics was 9.82% at the end of 20/2/2025 12:00:00 AM.

You can easily buy Krsnaa Diagnostics shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

Open Demat Account
+91 -

personImage
Open Demat Account
+91 -